Cubist Systematic Strategies, LLC Aligos Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.87 - $2.11 $11,561 - $28,039	13,289 Added 442966.66%	13,292 $11,000
Q4 2022 Feb 14, 2023	SELL	$0.89 - $28.0 $20 - $644	-23 Reduced 88.46%	3 $0
Q3 2022 Nov 14, 2022	SELL	$1.06 - $27.5 $4,066 - $105,490	-3,836 Reduced 99.33%	26 $0
Q2 2022 Aug 15, 2022	SELL	$1.04 - $2.14 $1,627 - $3,349	-1,565 Reduced 28.84%	3,862 $5,000
Q1 2022 May 16, 2022	BUY	$2.08 - $12.2 $834 - $4,892	401 Added 7.98%	5,427 $12,000
Q4 2021 Feb 14, 2022	BUY	$11.48 - $17.69 $57,698 - $88,909	5,026 New	5,026 $60,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.3B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.